Venetoclax Plus Lenalidomide
Phase I Clinical Trial of Bcl2 Inhibitor Venetoclax in Combination With Lenalidomide and Dexamethasone (Ven-Rd), Daratumumab and Dexamethasone (Ven-Dd), or Daratumumab-Lenalidomide-Dexamethasone (Ven-DRd) in t(11;14) Multiple Myeloma
Arms / Cohorts
Experimental, Arm A:Venetoclax + Daratumumab + Dexamethasone
Accepting patients
Experimental, Arm C:Venetoclax + Daratumumab + Lenalidomide + Dexamethasone
Accepting patients
Experimental, Arm B:Venetoclax + Lenalidomide + Dexamethasone
Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.